Insider Transactions in Q2 2023 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2023
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,839
-0.86%
|
$3,678
$2.35 P/Share
|
|
Jun 05
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,536
-0.44%
|
$7,072
$2.24 P/Share
|
|
Jun 02
2023
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
631
-0.26%
|
$1,262
$2.22 P/Share
|
|
May 04
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,805
-0.47%
|
$11,415
$3.35 P/Share
|
|
Apr 20
2023
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,770
-2.05%
|
$27,080
$4.04 P/Share
|
|
Apr 04
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,497
-0.43%
|
$10,491
$3.97 P/Share
|